p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression

被引：0
|
作者：
Tjoe, Judy [1 ]
Brittany, Last [2 ]
Yin, Jun [2 ]
机构：
[1] Advocate Aurora Hlth, Milwaukee, WI USA
[2] Aurora Res Inst, Milwaukee, WI USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582323
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Kim, HJ
    Jung, WH
    Kim, DY
    Lee, HD
    YONSEI MEDICAL JOURNAL, 2000, 41 (03) : 345 - 353
  • [2] Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast
    Mutasa, Simukayi
    Chang, Peter
    Nemer, John
    Van Sant, Eduardo Pascual
    Sun, Mary
    McIlvride, Alison
    Siddique, Maham
    Ha, Richard
    CLINICAL BREAST CANCER, 2020, 20 (06) : E757 - E760
  • [3] Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion
    Gobbi, H
    Jensen, RA
    Simpson, JF
    Olson, SJ
    Page, DL
    HUMAN PATHOLOGY, 2001, 32 (08) : 785 - 790
  • [4] Upstaging of Atypical Ductal Hyperplasia and Flat Epithelial Atypia to Ductal Carcinoma In Situ and Invasive Breast Cancer
    Lazar, M.
    Gresik, C.
    Sullivan, M.
    Helenowski, I.
    Khan, S.
    Bethke, K. P.
    Jeruss, J. S.
    Hansen, N. M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S50 - S51
  • [5] Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ
    Boecker, W
    Moll, R
    Dervan, P
    Buerger, H
    Poremba, C
    Diallo, RI
    Herbst, H
    Schmidt, A
    Lerch, MM
    Buchwalow, IB
    JOURNAL OF PATHOLOGY, 2002, 198 (04): : 458 - 467
  • [6] CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia
    Schmid, BC
    Rudas, M
    Rezniczek, GA
    Leodolter, S
    Zeillinger, R
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 84 (03) : 247 - 250
  • [7] CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia
    Bernd C. Schmid
    Margarethe Rudas
    Günther A. Rezniczek
    Sepp Leodolter
    Robert Zeillinger
    Breast Cancer Research and Treatment, 2004, 84 : 247 - 250
  • [8] TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Chitemerere, M
    Andersen, TI
    Holm, R
    Karlsen, F
    Borresen, AL
    Nesland, JM
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) : 103 - 109
  • [9] Active Surveillance for Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ
    Miceli, Rachel
    Mercado, Cecilia L.
    Hernandez, Osvaldo
    Chhor, Chloe
    JOURNAL OF BREAST IMAGING, 2023, 5 (04) : 396 - 415
  • [10] An MRI-Based Radiomics Nomogram to Distinguish Ductal Carcinoma In Situ with Microinvasion From Ductal Carcinoma In Situ of Breast Cancer
    Wu, Zengjie
    Lin, Qing
    Wang, Haibo
    Wang, Guanqun
    Fu, Guangming
    Bian, Tiantian
    ACADEMIC RADIOLOGY, 2023, 30 : S71 - S81
12345